Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases
Ironwood Pharmaceuticals, a GI-focused healthcare company, and VectivBio Holding AG, a clinical-stage biopharmaceutical company pioneering […]
Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
Stereotaxis today announced a global collaboration with Abbott to integrate Abbott’s EnSite™ X EP System […]
TraceLink Announces Appointment of George Llado, former Merck and Alexion CIO, to Board of Directors
TraceLink, the leading digital network platform company enabling end-to-end product orchestration by connecting more than […]
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics
Shanghai Stock Exchange-listed company HitGen announced today that it has entered into a research agreement […]
Discovery Life Sciences Joins Akoya Biosciences' Global Service Provider Network to Accelerate Immuno-oncology Research
Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, have announced that it has officially […]
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for […]
FzioMed Announces Addition of Industry Veteran to its Board of Directors
FzioMed, a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, […]
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the […]
Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors
Prothena, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on […]
Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors
Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more